- Obstructive - ‘ABCCF’ - Asthma, Bronchiectasis, COPD, Cystic fibrosis, Foreign body
- Difficult to exhale due to narrowed airway (harder to blow out)
- Total lung capacity - normal
- FEV1 reduced, FVC reduced or normal, FEV1/FVC ratio reduced
- Restrictive - ‘PAINT’ - Pleural (pleural effusion), Alveolar, Interstitial (interstitial lung
disease), Neuromuscular problems (muscular dystrophy, ALS), Thoracic cage disorders
(scoliosis)
- Difficult to inhale due to stiff lungs (less to blow out)
- Total lung capacity - reduced
- FEV1 reduced, FVC reduced, FEV1/FVC ratio normal
Normal Obstructive Restrictive
FEV1 >80% Reduced Reduced
FVC >80% Reduced or normal Reduced
FEV1/FVC ratio >70 Reduced Normal
Total lung capacity 4-6L Normal Reduced
RESPIRATORY FAILURE
Type I respiratory failure
- PaO2 low (<8kPa), PaCO2 normal/low (<6kPa) ie. hypoxia without hypercapnia
- Give controlled O2 via venturi device
- CPAP used if PaO2 <8kPa despite green 60% venturi device
Type II respiratory failure
, - PaO2 low (<8kPa), PaCO2 high (>6kPa) ie. hypoxia with hypercapnia
- Give controlled O2 starting at blue 24% venturi device, care needed
- BiPAP used if PaCO2 rising >1.5kPa and still hypoxic despite O2 therapy
ASTHMA
- Chronic reversible inflammation of the airways caused by increased sensitivity to various
stimuli leading to variable airflow obstruction
- Bronchial muscle contraction
- Mucosal swelling/inflammation
- Increased mucus production
- Samter’s triad - asthma + nasal polyps + aspirin sensitivity
- Sx: wheeze, non-productive cough, dyspnoea, chest tightness
- Dx: <5 years - clinical judgement; ≥5 years - spirometry with BDR ± FeNO (use in children
with diagnostic uncertainty and all adults)
- But no single way to dx asthma, most important to demonstrate reversibility
- PEF - variability >20%
- Spirometry with BDR - (obstructive pattern with reversibility) FEV1/FVC ratio <75,
reversibility ≥12%
- FeNO (fractional exhaled nitric oxide) - NO produced by 3 types of nitric oxide
synthases (NOS), once of the types is inducible (iNOS) and levels rise in
inflammatory cells, particularly eosinophils, so level of NO correlated with level of
inflammation
<5 years ≥5 years
1 SABA SABA
2 Trial of moderate-dose ICS Add low-dose
Review at 8w: ICS
- Sx didn’t resolve → review if asthma likely
- Sx resolved but recurred within 4w of stopping ICS → restart low-dose ICS
- Sx resolved but recurred after 4w of stopping ICS → repeat trial
3 Add LTRA Add LTRA
4 Stop LTRA and refer to specialist Add LABA
Acute asthma exacerbation
Moderate Severe Life-threatening Near-fatal
PEF 50-75% PEF 33-50% PEF <33% Needs ventilation
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller um19mma. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for £5.46. You're not tied to anything after your purchase.